| Robert B. Ford | Chairman of the Board and Chief Executive Officer | FY2025 | |
| Philip P. Boudreau | Executive Vice President, Finance and Chief Financial Officer | FY2025 | |
| Lisa D. Earnhardt | Executive Vice President and Group President, Medical Devices | FY2025 | |
| Hubert L. Allen | Former Executive Vice President, General Counsel and Secretary | FY2025 | |
| Christopher J. Scoggins | Executive Vice President, Diabetes Care | FY2025 | |
| Daniel G. Salvadori | Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products | FY2025 |
6 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.